Rep. Jonathan L. Jackson Sells Off Shares of Doximity, Inc. (NASDAQ:DOCS)

Representative Jonathan L. Jackson (D-Illinois) recently sold shares of Doximity, Inc. (NASDAQ:DOCS). In a filing disclosed on December 05th, the Representative disclosed that they had sold between $15,001 and $50,000 in Doximity stock on November 6th. The trade occurred in the Representative’s “MORGAN STANLEY TRUST ACCOUNT” account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 11/11/2025.
• Purchased $1,001 – $15,000 in shares of State Street (NYSE:STT) on 11/11/2025.
• Sold $1,001 – $15,000 in shares of T-Mobile US (NASDAQ:TMUS) on 11/11/2025.
• Purchased $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 11/6/2025.
• Purchased $1,001 – $15,000 in shares of Shopify (NASDAQ:SHOP) on 10/8/2025.
• Sold $1,001 – $15,000 in shares of McKesson (NYSE:MCK) on 10/8/2025.
• Purchased $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 10/8/2025.
• Purchased $15,001 – $50,000 in shares of Shopify (NASDAQ:SHOP) on 10/6/2025.

Doximity Trading Down 1.1%

NASDAQ DOCS traded down $0.51 on Tuesday, hitting $45.17. 3,663,066 shares of the stock traded hands, compared to its average volume of 2,136,686. The stock has a 50-day moving average of $60.21 and a 200 day moving average of $61.68. Doximity, Inc. has a twelve month low of $44.98 and a twelve month high of $85.21. The company has a market capitalization of $8.50 billion, a P/E ratio of 45.17, a price-to-earnings-growth ratio of 4.10 and a beta of 1.38.

Doximity (NASDAQ:DOCS) last issued its earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the business posted $0.30 earnings per share. The company’s revenue was up 23.2% compared to the same quarter last year. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of DOCS. Bank of Nova Scotia acquired a new stake in Doximity in the first quarter worth about $651,000. Jump Financial LLC bought a new stake in shares of Doximity during the 1st quarter worth about $3,125,000. Hsbc Holdings PLC lifted its stake in shares of Doximity by 752.1% in the 1st quarter. Hsbc Holdings PLC now owns 141,191 shares of the company’s stock worth $8,120,000 after acquiring an additional 124,622 shares during the period. Strs Ohio bought a new position in shares of Doximity in the first quarter valued at approximately $665,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of Doximity in the first quarter valued at approximately $801,000. Institutional investors own 87.19% of the company’s stock.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director owned 3,221 shares in the company, valued at $241,575. This represents a 86.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $66.44, for a total value of $132,880.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at $1,318,103.16. This represents a 9.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 32,000 shares of company stock valued at $2,339,580 over the last quarter. Corporate insiders own 31.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DOCS. Canaccord Genuity Group decreased their price objective on shares of Doximity from $67.00 to $58.00 and set a “hold” rating for the company in a report on Monday, November 10th. BMO Capital Markets began coverage on shares of Doximity in a report on Thursday, November 13th. They issued a “market perform” rating and a $55.00 price target for the company. JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $62.00 price objective on shares of Doximity in a research report on Friday, October 10th. Robert W. Baird raised their target price on shares of Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, September 11th. Finally, The Goldman Sachs Group set a $64.00 target price on Doximity and gave the company a “sell” rating in a research note on Wednesday, October 1st. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $67.95.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.

Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.